298
Views
1
CrossRef citations to date
0
Altmetric
Case Series

Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy

, , , , , , , , , , , , , , , & show all
Pages 393-407 | Published online: 22 Apr 2022

Figures & data

Figure 1 Molecular biology clearance.

Figure 1 Molecular biology clearance.

Figure 2 Haematological recovery.

Figure 2 Haematological recovery.

Figure 3 Consolidating pneumonia before starting gilteritinib.

Figure 3 Consolidating pneumonia before starting gilteritinib.

Figure 4 Evolution of the skin rash during the differentiation syndrome (A-F).

Figure 4 Evolution of the skin rash during the differentiation syndrome (A-F).

Figure 5 CT scans of submandibular and laterocervical sarcoma.

Figure 5 CT scans of submandibular and laterocervical sarcoma.

Figure 6 Evolution of the cutaneous sarcoma in a submandibular abscess.

Figure 6 Evolution of the cutaneous sarcoma in a submandibular abscess.

Figure 7 Evolution of the myeloid sarcoma during the treatment with gilteritinib.

Figure 7 Evolution of the myeloid sarcoma during the treatment with gilteritinib.

Figure 8 NPM1/FLT3-ITD assays.

Figure 8 NPM1/FLT3-ITD assays.